BioSpectrum India·3 min read·medium
ICMR transfers three indigenous biomedical technologies for advancements in cancer and infectious disease solutions
✦AI Summary
The Indian Council of Medical Research (ICMR) has licensed three indigenous biomedical technologies to pharmaceutical firms to advance cancer and infectious disease treatments. These include an anti-HPV therapeutic for cervical cancer and two next-generation bacterial infection vaccines.
The Indian Council of Medical Research (ICMR), under its Medical Innovation Patent Mitra initiative, has granted licenses to three indigenous biomedical technologies to leading Indian pharmaceutical and vaccine manufacturers for further development, production and commercialisation.
sciencehealthtechnology
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in